Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial. Medscape Medical News
Category: News
Trabeculectomy Often More Cost-Effective Than Tube Shunts
Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma. Medscape Medical News
Are Visual Deficits After Stroke Being Missed?
The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect up to three quarters of survivors. Medscape News Europe
Endophthalmitis a Risk for Years After Tube Shunt Surgery
The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds. Medscape Medical News
Does This ED Drug Harm the Retina?
The use of sildenafil is associated with an increased risk for serous retinal detachment in men with erectile dysfunction, a study finds. Medscape Medical News
Study Backs Longer Compounded Lido Plus Epi Shelf Life
Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration. Medscape Medical News
RevolutionEHR Launches RevPay, Redefining How Optometry Practices Manage Cash Flow
SAN DIEGO–(BUSINESS WIRE)– #DigitalPayments–RevolutionEHR, the market-leading optometry-first operating platform, today announced the launch of RevPay, its fully embedded payments solution designed to help practices get paid effortlessly while recov…
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that more than 4 million Implantable Col…
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
GENEVA–(BUSINESS WIRE)–Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
GENEVA–(BUSINESS WIRE)–Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced today that Ophthalmology and Therapy published a new global narrative re…
PET/CT Can Catch Cranial GCA Missed by Doppler Ultrasound
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement. Medscape Medical News
Dry Eye Disease May Occur Years Before Autoimmune Disease
Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds. Medscape Medical News
AGS 2026
Read clinically focused news coverage of key developments from AGS 2026 Medscape Ophthalmology
Diabetic Retinopathy Severity Tied to Rising Dementia Risk
Greater severity of diabetic retinopathy is associated with a stepwise increase in the risk for all-cause and vascular dementia in patients with type 2 diabetes. Medscape Medical News
Early Retinal Fluid Drying May Extend Injection Gaps in AMD
Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections. Medscape Medical News
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis
MALVERN, Pa.–(BUSINESS WIRE)–NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S. Food and Drug Administration…
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vyome announces the publication of positive preclinical results in uveitis, addressing a $3B potential market opportunity
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology
GENEVA–(BUSINESS WIRE)–Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology
Ocular Therapeutix’s Eye Drug Superior to Regeneron’s Eylea in Late-stage Trial
Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron’s approved treatment… Reuters Health Information